PDE4D
3',5'-cyclic-AMP phosphodiesterase 4D
Also known as: DPDE3, PDE4D_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q08499
- Gene
- PDE4D
- Ensembl
- ENSG00000113448
- Chromosome
- 5
- Canonical length
- 809 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear membrane,Plasma membrane,Primary cilium,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes one of four mammalian counterparts to the fruit fly 'dunce' gene. The encoded protein has 3',5'-cyclic-AMP phosphodiesterase activity and degrades cAMP, which acts as a signal transduction molecule in multiple cell types. This gene uses different promoters to generate multiple alternatively spliced transcript variants that encode functional proteins.[provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
809 residues, UniProt reviewed canonical sequence.
>Q08499|PDE4D
1 MEAEGSSAPA RAGSGEGSDS AGGATLKAPK HLWRHEQHHQ YPLRQPQFRL LHPHHHLPPP
61 PPPSPQPQPQ CPLQPPPPPP LPPPPPPPGA ARGRYASSGA TGRVRHRGYS DTERYLYCRA
121 MDRTSYAVET GHRPGLKKSR MSWPSSFQGL RRFDVDNGTS AGRSPLDPMT SPGSGLILQA
181 NFVHSQRRES FLYRSDSDYD LSPKSMSRNS SIASDIHGDD LIVTPFAQVL ASLRTVRNNF
241 AALTNLQDRA PSKRSPMCNQ PSINKATITE EAYQKLASET LEELDWCLDQ LETLQTRHSV
301 SEMASNKFKR MLNRELTHLS EMSRSGNQVS EFISNTFLDK QHEVEIPSPT QKEKEKKKRP
361 MSQISGVKKL MHSSSLTNSS IPRFGVKTEQ EDVLAKELED VNKWGLHVFR IAELSGNRPL
421 TVIMHTIFQE RDLLKTFKIP VDTLITYLMT LEDHYHADVA YHNNIHAADV VQSTHVLLST
481 PALEAVFTDL EILAAIFASA IHDVDHPGVS NQFLINTNSE LALMYNDSSV LENHHLAVGF
541 KLLQEENCDI FQNLTKKQRQ SLRKMVIDIV LATDMSKHMN LLADLKTMVE TKKVTSSGVL
601 LLDNYSDRIQ VLQNMVHCAD LSNPTKPLQL YRQWTDRIME EFFRQGDRER ERGMEISPMC
661 DKHNASVEKS QVGFIDYIVH PLWETWADLV HPDAQDILDT LEDNREWYQS TIPQSPSPAP
721 DDPEEGRQGQ TEKFQFELTL EEDGESDTEK DSGSQVEEDT SCSDSKTLCT QDSESTEIPL
781 DEQVEEEAVG EEEESQPEAC VIDDRSPDTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDE4D can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 71 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 71 nTPM
- skeletal muscle: 64 nTPM
- tongue: 33 nTPM
- blood vessel: 21 nTPM
- urinary bladder: 21 nTPM
- seminal vesicle: 20 nTPM
Single-cell type
- renal connecting tubule cells: 10,731 nCPM
- myonuclei: 8,671 nCPM
- prostatic glandular cells: 7,017 nCPM
- neutrophil progenitors: 5,306 nCPM
- salivary acinar cells: 5,022 nCPM
- renal collecting duct intercalated cells: 4,569 nCPM
Immune cell
- eosinophil: 58 nTPM
- naive B-cell: 11 nTPM
- memory B-cell: 11 nTPM
- basophil: 4.2 nTPM
- neutrophil: 3.1 nTPM
- classical monocyte: 2 nTPM
Brain region
- cerebral cortex: 81 nTPM
- basal ganglia: 70 nTPM
- white matter: 69 nTPM
- medulla oblongata: 62 nTPM
- thalamus: 61 nTPM
- hypothalamus: 58 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PDE4D.
Disease | AllUniProt
Conditions PDE4D is implicated in, by any mechanism.
- Acrodysostosis 2, with or without hormone resistance (ACRDYS2) MIM:614613
Disease | GeneticClinVar
25 pathogenic / likely-pathogenic of 669 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Acrodysostosis 2 with or without hormone resistance
- Metaphyseal acroscyphodysplasia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.21
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.75
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adrenergic receptor signaling pathway
- cAMP catabolic process
- cellular response to cAMP
- cellular response to epinephrine stimulus
- establishment of endothelial barrier
- negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway
- negative regulation of cAMP/PKA signal transduction
- negative regulation of heart contraction
- negative regulation of relaxation of cardiac muscle
- positive regulation of heart rate
- positive regulation of interleukin-2 production
- positive regulation of interleukin-5 production
- positive regulation of type II interferon production
- regulation of calcium ion transmembrane transport via high voltage-gated calcium channel
- regulation of cardiac muscle cell contraction
- regulation of cell communication by electrical coupling involved in cardiac conduction
- regulation of heart rate
- regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
- T cell receptor signaling pathway
Molecular functions
- 3',5'-cyclic-AMP phosphodiesterase activity
- 3',5'-cyclic-GMP phosphodiesterase activity
- 3',5'-cyclic-nucleotide phosphodiesterase activity
- ATPase binding
- beta-2 adrenergic receptor binding
- calcium channel regulator activity
- cAMP binding
- enzyme binding
- heterocyclic compound binding
- metal ion binding
- scaffold protein binding
- signaling receptor regulator activity
- transmembrane transporter binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain
- 3'5'-cyclic nucleotide phosphodiesterase
- 3'5'-cyclic nucleotide phosphodiesterase, conserved site
- 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain superfamily
- Phosphodiesterase 4 upstream conserved regions (UCR)
- 3'5'-cyclic nucleotide phosphodiesterase
- Phosphodiesterase 4 upstream conserved regions (UCR)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PDE4D in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDE4D as an antibody target. Whether an autoantibody or antibody against PDE4D could matter depends on whether native PDE4D is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDE4D is annotated at the cell surface, where native PDE4D is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PDE4D as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...